SAN DIEGO -- Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial ...

Sanofi’s Dupixent (dupilumab) has been cleared for NHS funding in Wales and Scotland in adolescents with severe eczema, also known as atopic dermatitis. The decisions from the All Wales ...

Sanofi has upped its revenue forecasts for the year on the back of strong second quarter results from its new eczema and asthma injection Dupixent and its rare diseases and vaccines businesses.